Skip to content

Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia

Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia: A Randomized Double Blinded Investigational Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02892994
Enrollment
23
Registered
2016-09-08
Start date
2016-04-30
Completion date
2016-06-30
Last updated
2016-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular Joint Dysfunction Syndrome

Keywords

therapeutic ultrasound

Brief summary

This study will compare ultrasound 0.4 W/cm\^2 and 100% duty cycle versus no ultrasound (placebo) for bilateral masseter myalgia in up to 38 adult women. The dose will be applied for 5 minutes on each side. Both the dose and the starting side will be randomized. Both the subject and ultrasound operator will be blind to the dose. The outcome measures will be pressure pain threshold on both masseter muscles and both temporalis muscles, self reported pain scale (0, no pain to 10, worst pain ever), thermographic temperature of the muscles, and intraoral temperature. These outcome measures will be taken before and after each dose, so three times per subject.

Interventions

OTHERultrasound

Sponsors

State University of New York at Buffalo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adult females Bilateral myalgia based on Diagnostic Criteria for TMD (DC-TMD) (Schiffman, et al., 2014) Current pain intensity ≥4 out of 10, (where 0 is no pain and 10 is the worst pain ever) on both sides.

Exclusion criteria

History or diagnosis of systemic musculoskeletal disorders. Rheumatologic diseases (e.g. fibromyalgia, muscular atrophy). Certain conditions such as neoplasms or fractures. Neuropathies or neurological disorders. Currently taking muscle relaxants or analgesics. Any form of physical therapy within the last 60 days.

Design outcomes

Primary

MeasureTime frameDescription
Pressure pain threshold, change from pre- to post-ultrasound dose.Immediate. Data taken before and after each dose, so three times in the one session which lasts about one hour to completion..The change in pressure pain threshold from before to after the ultrasound (or placebo) will be averaged over the two masseter muscles, and over the two temporalis muscles.
Self reported pain scale, change from pre- to post-ultrasound dose which lasts about one hour to completion.Immediate. Data taken before and after each dose, so three times in the one session.The change in self reported pain scale from before to after the ultrasound (or placebo) will be averaged over the two masseter muscles, and over the two temporalis muscles.
Intraoral temperatureImmediate. Data taken before and after each dose, so three times in the one session which lasts about one hour to completion.The intraoral temperature in the buccal area near the masseter muscle will be recorded before and after the ultrasound
Thermographic temperature of the musclesImmediate. Data taken before and after each dose, so three times in the one session which lasts about one hour to completion.The thermographic temperature of each masseter and each temporalis muscle will be recorded before and after the ultrasound.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026